Physician profile
Mitchell Essig
NPI 1316044357
$4,827.83
in general payments reported to CMS, 2019-2025
24 companies · $868 in 2025
The $868 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $942 · 2020: $321 · 2021: $618 · 2022: $1,032 · 2023: $624 · 2024: $423 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,915.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,424.99 | 2019-2023 | |
| Astellas Pharma US INC | $579.00 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $456.18 | 2022-2025 | |
| Myovant Sciences INC. | $412.52 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $341.78 | 2023-2025 | Myfembree |
| Ferring Pharmaceuticals INC. | $284.46 | 2019-2021 | |
| Lupin INC. | $201.77 | 2019-2020 | |
| Therapeuticsmd, INC. | $184.52 | 2019-2021 | |
| Pfizer INC. | $159.11 | 2019-2022 | |
| Biogen, INC. | $144.81 | 2025 | Zurzuvae |
| Mindray Ds USA, INC. | $109.64 | 2025 | Te X, Te7 Max |
| Coopersurgical, INC. | $84.86 | 2025 | Paragard T 380a, Endosee |
| Allergan, INC. | $81.54 | 2019-2020 | |
| Exeltis, USA INC. | $61.80 | 2025 | Slynd |
| Organon LLC | $51.17 | 2024-2025 | Nexplanon |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $49.26 | 2019 | |
| Agile Therapeutics, INC. | $42.40 | 2022 | |
| Scynexis, INC. | $34.24 | 2022 | |
| Amgen INC. | $27.55 | 2019 | |
| Avion Pharmaceuticals | $24.51 | 2022 | |
| Exact Sciences Corporation | $22.86 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $19.07 | 2025 | |
| Evofem Biosciences, INC. | $18.94 | 2021 | |
| Mission Pharmacal Company | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Essig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.